Endothelin receptor antagonist

From Wikipedia, the free encyclopedia

You have new messages (last change).

A endothelin receptor antagonist (ERA) is a drug which blocks endothelin receptors.

Two main kinds of ERAs exist:

  • selective ERA (e.g. sitaxsentan), which affect endothelin A.
  • dual ERAs,(e.g. bosentan) which affect both endothelin A and B .[1]

[edit] See also

[edit] References

  1. ^ http://cvpharmacology.com/vasodilator/ETblockers.htm
 This medical treatment article is a stub. You can help Wikipedia by expanding it.
v • d • e
Medications used in the management of pulmonary arterial hypertension (B01, C02)
Prostacyclin analogues Beraprost, Epoprostenol, Iloprost, Treprostinil
Endothelin receptor antagonists Ambrisentan, Bosentan, Sitaxsentan
PDE5 inhibitors Sildenafil, Tadalafil
Adjunctive therapy Calcium channel blockers, Diuretics, Digoxin, Oxygen therapy, Warfarin anticoagulation
Retrieved from "http://en.wikipedia.org../../../e/n/d/Endothelin_receptor_antagonist.html"